Form 4: Orasure CFO McGrath Reports Equity Compensation

Orasure Technologies CFO Kenneth J. McGrath reported recent equity transactions, including restricted stock grants and tax-related share dispositions.

Summary

• Kenneth J. McGrath, Chief Financial Officer of Orasure Technologies Inc. (OSUR), reported several transactions involving the company's common stock.
• On March 1, 2026, McGrath acquired 26,814 shares of common stock at a price of $0, representing the settlement of vested performance units.
• Also on March 1, 2026, McGrath disposed of 7,639 shares at $3.0425 to cover tax liabilities associated with the vesting of performance units.
• An additional 20,745 shares were disposed of on March 1, 2026, at $3.0425 to satisfy tax liabilities related to the vesting of restricted shares.
• On March 2, 2026, McGrath was granted 88,348 shares of common stock as a restricted stock award, with a price of $0.
• Following these transactions, McGrath's direct beneficial ownership of common stock increased to 535,241 shares.
• The restricted stock award granted on March 2, 2026, will vest in three equal annual installments, commencing on March 2, 2027, contingent on continuous service.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that align management incentives with shareholder value through equity grants and performance-based awards.

Positives

• The grant of 88,348 restricted stock units to the CFO aligns management's interests with long-term shareholder value.
• The vesting of performance units, resulting in the acquisition of 26,814 shares, indicates the achievement of previously set performance targets.

Future Outlook

The restricted stock award granted to the CFO is structured to vest in three equal annual installments starting March 2, 2027, contingent on continuous service, indicating a commitment to long-term executive retention and performance alignment.

Industry Context

StockSavvy.ai notes that executive compensation, particularly through equity grants like restricted stock and performance units, is a standard practice across the biotechnology and diagnostics industry. This approach aims to incentivize long-term performance and align the interests of key executives with those of shareholders. The reported transactions are consistent with typical compensation structures for a Chief Financial Officer at a publicly traded company.

Stakeholder Impact

• Shareholders: The equity grants to the CFO are intended to align management's long-term interests with shareholder value creation.
• Employees: The vesting schedule for the restricted stock award incentivizes the CFO's continued service and commitment to the company.

Next Steps

• The restricted stock award will vest in three equal annual installments, with the first installment occurring on March 2, 2027, subject to the CFO's continuous service.

Key Dates

Keywords

OSUR, Orasure Technologies, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Award, Performance Units, CFO, Equity Grant